← Leaderboards
Mei-Zhen Cui
University Of Tennessee Knoxville
$6,563,539
Attributed
$6,563,539
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $945.2K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,563,539 · 4
By mechanism
R01$6,235,906 · 3
R21$327,633 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tennessee Knoxville
Same institution · by research overlap
- Xuemin Xu$4,471,889
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingKnockout MiceMouse ModelEventPathway InteractionsMolecularBlood VesselsPreventionPhosphotransferasesIn VivoCell MotilityCardiovascular DiseasesBaseDisabilityArteriesFocal Adhesion Kinase 1LesionIntegrinsInnovationCause Of DeathCyr61 ProteinPlayPreventRestenosis
Grant awards (18)
The Matricellular Protein Cyr61 Signaling Axis in Arterial Restenosis$484,198
R01 · FY2023 · HL · contact PI
The Matricellular Protein Cyr61 Signaling Axis in Arterial Restenosis$484,198
R01 · FY2022 · HL · contact PI
The Matricellular Protein Cyr61 Signaling Axis in Arterial Restenosis$484,198
R01 · FY2021 · HL · contact PI
The Matricellular Protein Cyr61 Signaling Axis in Arterial Restenosis$484,198
R01 · FY2020 · HL · contact PI
Novel mechanism mediating LPA-induced smooth muscle cell and vascular responses$460,967
R01 · FY2020 · HL · contact PI
Novel mechanism mediating LPA-induced smooth muscle cell and vascular responses$460,967
R01 · FY2019 · HL · contact PI
Novel mechanism mediating LPA-induced smooth muscle cell and vascular responses$497,717
R01 · FY2018 · HL · contact PI
Novel mechanism mediating LPA-induced smooth muscle cell and vascular responses$460,967
R01 · FY2017 · HL · contact PI
Pathogenic role of the novel mitochondrial apoptotic protein PSAP in ALS$107,133
R21 · FY2017 · NS · contact PI
Pathogenic role of the novel mitochondrial apoptotic protein PSAP in ALS$220,500
R21 · FY2016 · NS · contact PI
Novel mechanism mediating LPA-induced smooth muscle cell and vascular responses$357,700
R01 · FY2014 · HL · contact PI
Novel mechanism mediating LPA-induced smooth muscle cell and vascular responses$347,480
R01 · FY2013 · HL · contact PI
Novel mechanism mediating LPA-induced smooth muscle cell and vascular responses$365,000
R01 · FY2012 · HL · contact PI
Novel mechanism mediating LPA-induced smooth muscle cell and vascular responses$365,000
R01 · FY2011 · HL · contact PI
Lysophosphatidic acid & tissue factor in atherosclerosis$240,270
R01 · FY2007 · HL · contact PI
Lysophosphatidic acid & tissue factor in atherosclerosis$247,446
R01 · FY2006 · HL · contact PI
Lysophosphatidic acid &tissue factor in atherosclerosis$253,400
R01 · FY2005 · HL
Lysophosphatidic acid &tissue factor in atherosclerosis$242,200
R01 · FY2004 · HL